SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,757,619 | -14.2% | 1,020,934 | -18.9% | 0.32% | -13.6% |
| Q2 2023 | $144,230,382 | -11.0% | 1,259,434 | +7.1% | 0.37% | -12.2% |
| Q1 2023 | $162,051,417 | +105.1% | 1,175,734 | +92.9% | 0.42% | +89.1% |
| Q4 2022 | $78,996,374 | +33.7% | 609,634 | +14.1% | 0.22% | +29.2% |
| Q3 2022 | $59,076,000 | +183.1% | 534,434 | +91.9% | 0.17% | +189.8% |
| Q2 2022 | $20,871,000 | -21.3% | 278,434 | -17.9% | 0.06% | -15.7% |
| Q1 2022 | $26,509,000 | -35.5% | 339,334 | -25.7% | 0.07% | -32.0% |
| Q4 2021 | $41,102,000 | +1330.1% | 456,434 | +2465.4% | 0.10% | +1371.4% |
| Q3 2018 | $2,874,000 | -74.6% | 17,792 | -79.2% | 0.01% | -76.7% |
| Q2 2018 | $11,327,000 | +314.8% | 85,692 | +132.5% | 0.03% | +328.6% |
| Q1 2018 | $2,731,000 | +727.6% | 36,858 | +586.9% | 0.01% | +600.0% |
| Q3 2016 | $330,000 | -63.5% | 5,366 | -80.9% | 0.00% | -83.3% |
| Q3 2015 | $904,000 | – | 28,166 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |